Among nine known immune checkpoints (CTLA4, PD-L1, PD-L2, PD-1, SIGLEC15, TIM3, TIGIT, IDO1, and LAG3), there was no difference between normal and tumor samples (Supplementary Figure 5). This evidence concerns the gene SIGLEC15 and neoplasm.